The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Pyruvate carboxylase is critical for non–small-cell lung cancer proliferation
Open accessAbstract
Anabolic biosynthesis requires precursors supplied by the Krebs cycle, which in turn requires anaplerosis to replenish precursor intermediates. The major anaplerotic sources are pyruvate and glutamine, which require the activity of pyruvate carboxylase (PC) and glutaminase 1 (GLS1), respectively. Due to their rapid proliferation, cancer cells have increased anabolic and energy demands; however, different cancer cell types exhibit differential requirements for PC- and GLS-mediated pathways for anaplerosis and cell proliferation. Here, we infused patients with early-stage non-small-cell lung cancer (NSCLC) with uniformly 13C-labeled glucose before tissue resection and determined that the cancerous tissues in these patients had enhanced PC activity. Freshly resected paired lung tissue slices cultured in 13C6-glucose or 13C5,15N2-glutamine tracers confirmed selective activation of PC over GLS in NSCLC. Compared with noncancerous tissues, PC expression was greatly enhanced in cancerous tissues, whereas GLS1 expression showed no trend. Moreover, immunohistochemical analysis of paired lung tissues showed PC overexpression in cancer cells rather than in stromal cells of tumor tissues. PC knockdown induced multinucleation, decreased cell proliferation and colony formation in human NSCLC cells, and reduced tumor growth in a mouse xenograft model. Growth inhibition was accompanied by perturbed Krebs cycle activity, inhibition of lipid and nucleotide biosynthesis, and altered glutathione homeostasis. These findings indicate that PC-mediated anaplerosis in early-stage NSCLC is required for tumor survival and proliferation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In fact, tracing the fate of glucose-derived carbons in human patients and in mouse models of glioblastoma and non-small cell lung carcinoma (NSCLC) reveals that at least in these tumorigenic contexts, the principal source for the TCA cycle intermediates is not glutamine, but glucose (Maher et al., 2012; Marin-Valencia et al., 2012; Sellers et al., 2015).”
From The emerging hallmarks of cancer metabolism (2016) · cites this paper as Sellers et al., 2015
In the citing paper
“Although PDC and PC both catalyze the flux of pyruvate into the TCA cycle, their enzymatic activities can be distinguished by stable isotope tracing26,27, and their metabolic roles do not appear to be interchangeable.”
From The multifaceted contributions of mitochondria to cellular metabolism (2018) · cites this paper as [27]
In the citing paper
“Many cancers favor PC-mediated anaplerosis, although the factors that dictate the choice for pyruvate flux between PC and PDC are little studied.27,29,30”
From The multifaceted contributions of mitochondria to cellular metabolism (2018) · cites this paper as [27]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197
Warburg, O. (1956) · Science · doi:10.1126/science.123.3191.309 · Cited by 13,425
Fundamentals of Biostatistics.
(1969) · Annals of Internal Medicine · doi:10.7326/0003-4819-70-4-873 · Cited by 4,573
DeBerardinis, R. J., Mancuso, A., Daikhin, E., Nissim, I., Yudkoff, M., Wehrli, S., & Thompson, C. B. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709747104 · Cited by 2,622
Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia
Metallo, C. M., Gameiro, P. A., Bell, E. L., Mattaini, K. R., Yang, J., Hiller, K., Jewell, C. M., Johnson, Z. R., Irvine, D. J., Guarente, L., et al. (2012) · Nature · doi:10.1038/nature10602 · Cited by 1,791
Functional genomics reveal that the serine synthesis pathway is essential in breast cancer
Possemato, R., Marks, K. M., Shaul, Y. D., Pacold, M. E., Kim, D., Birsoy, K., Sethumadhavan, S., Woo, H.-K., Jang, H. G., Jha, A. K., et al. (2011) · Nature · doi:10.1038/nature10350 · Cited by 1,683
Reductive carboxylation supports growth in tumour cells with defective mitochondria
Mullen, A. R., Wheaton, W. W., Jin, E. S., Chen, P.-H., Sullivan, L. B., Cheng, T., Yang, Y., Linehan, W. M., Chandel, N. S., & DeBerardinis, R. J. (2012) · Nature · doi:10.1038/nature10642 · Cited by 1,328
Oncogenic alterations of metabolism
Dang, C. V., & Semenza, G. L. (1999) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(98)01344-9 · Cited by 1,106
Glucose-Independent Glutamine Metabolism via TCA Cycling for Proliferation and Survival in B Cells
Le, A., Lane, A. N., Hamaker, M., Bose, S., Gouw, A., Barbi, J., Tsukamoto, T., Rojas, C. J., Slusher, B. S., Zhang, H., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2011.12.009 · Cited by 1,095
Self-citation
Flagged first, then by citations
Research works printed but not linked: 6
- Serkova, 2007, Curr Opin Mol Ther., 9, 572
- Mazurek, 2000, Anticancer Res., 20, 5151
- Warburg, 1923, Biochem Zeitschr., 142, 317
- Mazurek, 2003, Anticancer Res., 23, 1149
- Lobo, 2000, Biochem J., 348, 257, 10.1042/0264-6021:3480257 · DOI · Paper page
- 10.1016/j.cmet.2012.05.001 · DOI · Paper page
Cited by
Sorted by citations
Items 201–300 of 500
Measurement of metabolic fluxes using stable isotope tracers in whole animals and human patients
Reisz, J. A., & D’Alessandro, A. (2017) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0000000000000393 · Cited by 37
The metabolic adaptation mechanism of metastatic organotropism
Wang, C., & Luo, D. (2021) · Experimental Hematology and Oncology · doi:10.1186/s40164-021-00223-4 · Cited by 40
Glucose Limitation Alters Glutamine Metabolism in MUC1-Overexpressing Pancreatic Cancer Cells
Gebregiworgis, T., Purohit, V., Shukla, S. K., Tadros, S., Chaika, N. V., Abrego, J., Mulder, S. E., Gunda, V., Singh, P. K., & Powers, R. (2017) · Journal of Proteome Research · doi:10.1021/acs.jproteome.7b00246 · Cited by 39
Serine racemase enhances growth of colorectal cancer by producing pyruvate from serine
Ohshima, K., Nojima, S., Tahara, S., Kurashige, M., Kawasaki, K., Hori, Y., Taniguchi, M., Umakoshi, Y., Okuzaki, D., Wada, N., et al. (2020) · Nature Metabolism · doi:10.1038/s42255-019-0156-2 · Cited by 36
Metabolic Strategies for Inhibiting Cancer Development
Icard, P., Loi, M., Wu, Z., Ginguay, A., Lincet, H., Robin, E., Coquerel, A., Berzan, D., Fournel, L., & Alifano, M. (2020) · Advances in Nutrition · doi:10.1093/advances/nmaa174 · Cited by 36
Amino acid metabolic reprogramming in tumor metastatic colonization
Wang, Z., Wu, X., Chen, H., & Wang, K. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1123192 · Cited by 35
Kim, E., Kim, S., Nam, J., Sung, E., Song, I., Kim, J., Kwon, T. K., & Lee, T. J. (2016) · Oncotarget · doi:10.18632/oncotarget.7149 · Cited by 35
“Pyruvate Carboxylase, Structure and Function”
Valle, M. (2017) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-3-319-46503-6_11 · Cited by 35
The Many Facets of Tumor Heterogeneity: Is Metabolism Lagging Behind?
Loponte, S., Lovisa, S., Deem, A. K., Carugo, A., & Viale, A. (2019) · Cancers · doi:10.3390/cancers11101574 · Cited by 36
Active mitochondrial respiration in cancer: a target for the drug
Bedi, M., Ray, M., & Ghosh, A. (2021) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-021-04281-4 · Cited by 34
Kitazawa, S., Ebara, S., Ando, A., Baba, Y., Satomi, Y., Soga, T., & Hara, T. (2017) · Oncotarget · doi:10.18632/oncotarget.15959 · Cited by 35
Linden, C. V., & Corbet, C. (2019) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2019.05.016 · Cited by 34
c-Myc directly targets an over-expression of pyruvate carboxylase in highly invasive breast cancer
Lao-On, U., Rojvirat, P., Chansongkrow, P., Phannasil, P., Siritutsoontorn, S., Charoensawan, V., & Jitrapakdee, S. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2019.165656 · Cited by 33
Metabolic therapy and bioenergetic analysis: The missing piece of the puzzle
Duraj, T., Carrión-Navarro, J., Seyfried, T. N., Garcia‐Romero, N., & Ayuso‐Sacido, Á. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2021.101389 · Cited by 36
The metabolomic signature of hematologic malignancies
Allegra, A., Innao, V., Gerace, D. G., Bianco, O., & Musolino, C. (2016) · Leukemia Research · doi:10.1016/j.leukres.2016.08.002 · Cited by 32
Strategies for Extending Metabolomics Studies with Stable Isotope Labelling and Fluxomics
Srivastava, A., Kowalski, G. M., Callahan, D. L., Meikle, P. J., & Creek, D. J. (2016) · Metabolites · doi:10.3390/metabo6040032 · Cited by 33
Altered Mitochondrial Signalling and Metabolism in Cancer
Chattopadhyay, E., & Roy, B. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00043 · Cited by 36
Yang, H., Shen, J.-X., Wang, Y., Liu, Y., Shen, D., & Quan, S. (2019) · BioMed Research International · doi:10.1155/2019/2686340 · Cited by 33
Self-citationGonzalez‐Rivera, J. C., Baldridge, K. C., Wang, D., Patel, K., Chuvalo-Abraham, J. C. L., Ruiz, L. H., & Contreras, L. M. (2020) · Communications Biology · doi:10.1038/s42003-020-01118-6 · Cited by 35
Integration of Mitochondrial Targeting for Molecular Cancer Therapeutics
Marchetti, P., Guerreschi, P., Mortier, L., & Kluza, J. (2015) · International Journal of Cell Biology · doi:10.1155/2015/283145 · Cited by 39
Niu, N., Ye, J., Hu, Z., Zhang, J., & Wang, Y. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24087076 · Cited by 34
Self-citationTumor energy metabolism: implications for therapeutic targets
Hu, Y., Liu, W., Fang, W., Dong, Y., Zhang, H., & Luo, Q. (2024) · Molecular Biomedicine · doi:10.1186/s43556-024-00229-4 · Cited by 32
Metabolic Regulation in Mitochondria and Drug Resistance
Pan, Y., Cao, M., Liu, J., Yang, Q. K., Miao, X., Go, V. L. W., Lee, P. W. N., & Xiao, G. G. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-981-10-6674-0_11 · Cited by 33
Pyruvate carboxylase promotes thyroid cancer aggressiveness through fatty acid synthesis
Liu, C., Zhou, X., Pan, Y., Liu, Y., & Zhang, Y. (2021) · BMC Cancer · doi:10.1186/s12885-021-08499-9 · Cited by 32
Immunosurveillance encounters cancer metabolism
Chuang, Y., Tzeng, S., Ho, P., & Tsai, C. (2024) · EMBO Reports · doi:10.1038/s44319-023-00038-w · Cited by 33
Hypoxic adaptation of mitochondria and its impact on tumor cell function
Benej, M., Papandreou, I., & Denko, N. C. (2024) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2024.03.004 · Cited by 33
Cao, Z., Zhou, Y., Zhu, S., Feng, J. J., Chen, X., Liu, S., Peng, N., Yang, X., Xu, G., & Zhu, Y. (2016) · Scientific Reports · doi:10.1038/srep22002 · Cited by 31
A Mitochondrial-targeted purine-based HSP90 antagonist for leukemia therapy
Bryant, K. G., Chae, Y. C., Martinez, R. L., Gordon, J. C., Elokely, K. M., Kossenkov, A. V., Grant, S., Childers, W. E., Abou-Gharbia, M. A., & Altieri, D. C. (2017) · Oncotarget · doi:10.18632/oncotarget.23097 · Cited by 30
Gammon, S. T., Pisaneschi, F., Bandi, M. L., Smith, M. G., Sun, Y., Rao, Y., Müller, F. L., Wong, F. C., de Groot, J., Ackroyd, J. J., et al. (2019) · Cells · doi:10.3390/cells8121487 · Cited by 34
Gonsalves, W. I., Jang, J. S., Jessen, E., Hitosugi, T., Evans, L. A., Jevremović, D., Pettersson, X.-M., Bush, A. G., Gransee, J., Anderson, E. I., et al. (2020) · Cancer & Metabolism · doi:10.1186/s40170-020-00235-4 · Cited by 34
A pan-cancer transcriptomic study showing tumor specific alterations in central metabolism
Sheraj, I., Güray, T., & Banerjee, S. (2021) · Scientific Reports · doi:10.1038/s41598-021-93003-3 · Cited by 31
Lane, A. N., Higashi, R. M., & Fan, T. W. ‐. (2016) · Metabolomics · doi:10.1007/s11306-016-1065-y · Cited by 32
Self-citationLorkiewicz, P., Gibb, A., Rood, B. R., He, L., Zheng, Y., Clem, B. F., Zhang, X., & Hill, B. G. (2019) · Scientific Reports · doi:10.1038/s41598-019-50183-3 · Cited by 32
Kumari, R., Palaniyandi, S., & Hildebrandt, G. C. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.588449 · Cited by 32
Innate immune activation by checkpoint inhibition in human patient-derived lung cancer tissues
Fan, T. W. ‐., Higashi, R. M., Song, H., Daneshmandi, S., Mahan, A. L., Purdom, M. S., Bocklage, T. J., Pittman, T. A., He, D., Wang, C., et al. (2021) · eLife · doi:10.7554/elife.69578 · Cited by 29
Self-citation13C tracer analysis suggests extensive recycling of endogenous CO2 in vivo
Duan, L., Cooper, D. E., Scheidemantle, G. M., Locasale, J. W., Kirsch, D. G., & Liu, X. (2022) · Cancer & Metabolism · doi:10.1186/s40170-022-00287-8 · Cited by 31
Mitochondria in Cancer Energy Metabolism: Culprits or Bystanders?
Kim, A. (2015) · Toxicological Research · doi:10.5487/tr.2015.31.4.323 · Cited by 30
Reed, M. A. C., Ludwig, C., Bunce, C. M., Khanim, F. L., & Günther, U. L. (2016) · Cancer & Metabolism · doi:10.1186/s40170-016-0155-7 · Cited by 30
Glutaminase Inhibition on NSCLC Depends on Extracellular Alanine Exploitation
Caiola, E., Colombo, M., Sestito, G., Lupi, M., Marabese, M., Pastorelli, R., Broggini, M., & Brunelli, L. (2020) · Cells · doi:10.3390/cells9081766 · Cited by 29
Mitochondria in cancer: clean windmills or stressed tinkerers?
Altieri, D. C. (2022) · Trends in Cell Biology · doi:10.1016/j.tcb.2022.08.001 · Cited by 29
Isotope tracing in health and disease
Dong, W., Rawat, E. S., Stephanopoulos, G. N., & Abu-Remaileh, M. (2022) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2022.102739 · Cited by 26
Renoult, O., Gratas, C., Joalland, N., Laurent—Blond, M., Awada, H., Bourgeois, M., Oliver, L., Chiavassa, S., Croyal, M., Paris, F., et al. (2024) · Neuro-Oncology · doi:10.1093/neuonc/noae106 · Cited by 30
Exogenous pyruvate facilitates cancer cell adaptation to hypoxia by serving as an oxygen surrogate
Yin, C., He, D., Chen, S., Tan, X., & Sang, N. (2016) · Oncotarget · doi:10.18632/oncotarget.10202 · Cited by 28
Hatakeyama, H., Fujiwara, T., Sato, H., Terui, A., & Hisaka, A. (2018) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b17-00992 · Cited by 28
Im, D.-K., Cheong, H., Lee, J.-S., Oh, M., & Yang, K. M. (2019) · Scientific Reports · doi:10.1038/s41598-019-41852-4 · Cited by 28
Iqbal, M. S., Luo, B., Mehmood, R., Alrige, M., & Alharbey, R. (2019) · IEEE Access · doi:10.1109/access.2019.2925041 · Cited by 28
Hong, J., Xie, Z., Yang, F., Jiang, L., Jian, T., Wang, S., Guo, Y., & Huang, X. (2022) · Fitoterapia · doi:10.1016/j.fitote.2022.105136 · Cited by 28
Zhou, Y.-J., Yu, H., Cheng, S., Chen, Y., He, L., Ren, J., He, X. Q., Chen, J., Zheng, L., Li, F., et al. (2022) · Journal of Cancer · doi:10.7150/jca.64195 · Cited by 28
Transient Systemic Autophagy Inhibition Is Selectively and Irreversibly Deleterious to Lung Cancer
Khayati, K., Bhatt, V. D., Lan, T., Alogaili, F., Wang, W., Lopez, E., Hu, Z. S., Gokhale, S., Cassidy, L. D., Narita, M., et al. (2022) · Cancer Research · doi:10.1158/0008-5472.can-22-1039 · Cited by 28
Ngamkham, J., Thuwajit, C., Thuwajit, P., Khamwachirapithak, P., Lertsuwan, K., Charoensawan, V., & Jitrapakdee, S. (2020) · Anticancer Research · doi:10.21873/anticanres.14649 · Cited by 28
Pyruvate anaplerosis is a targetable vulnerability in persistent leukaemic stem cells
Rattigan, K. M., Brabcová, Z., Sarnello, D., Zarou, M. M., Roy, K., Kwan, R. S.-Y., de Beauchamp, L., Dawson, A., Ianniciello, A., Khalaf, A., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-40222-z · Cited by 28
Linghu, T., Gao, Y., Li, A., Shi, B., Tian, J., & Qin, X. (2020) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2020.113588 · Cited by 27
Shining a light on metabolic vulnerabilities in non-small cell lung cancer
Dowling, C. M., Zhang, H., Chonghaile, T. N., & Wong, K.-K. (2021) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2020.188462 · Cited by 26
“Moreover, early stage NSCLC patients have increased PC activity, and freshly resected lung tissue samples labelled with glutamine tracers have significantly less GLS activity, when compared to PC activity [25].”
BackgroundInfluentialConvergence of Cancer Metabolism and Immunity: an Overview
Dang, C. V., & Kim, J. (2017) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2017.194 · Cited by 25
Does Tumor FDG-PET Avidity Represent Enhanced Glycolytic Metabolism in Non-Small Cell Lung Cancer?
Kernstine, K. H., Faubert, B., Do, Q. N., Rogers, T. J., Hensley, C. T., Cai, L., Torrealba, J. R., Oliver, D., Wachsmann, J., Lenkinski, R. E., et al. (2019) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2019.10.061 · Cited by 25
Preclinical Models for the Study of Lung Cancer Pathogenesis and Therapy DevelopmentPreprint
Estape, A. A., Foggetti, G., Starrett, J. H., Nguyen, D. X., & Politi, K. A. (2021) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a037820 · Cited by 23
Liu, X., Wang, W., Zhang, X., Liang, J., Dingqing, F., Li, Y., Xue, M., & Ling, B. (2024) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2024.102155 · Cited by 28
Cai, L., Hammond, N. G., Tasdogan, A., Alsamraae, M., Yang, C., Cameron, R. B., Quan, P., Solmonson, A., Gu, W., Pachnis, P., et al. (2025) · Cancer Discovery · doi:10.1158/2159-8290.cd-23-1319 · Cited by 28
Oxidative and Glycolytic Metabolism: Their Reciprocal Regulation and Dysregulation in Cancer
Cordani, M., Rumio, C., Bontempi, G., Strippoli, R., & Marcucci, F. (2025) · Cells · doi:10.3390/cells14151177 · Cited by 28
Impaired G2/M cell cycle arrest induces apoptosis in pyruvate carboxylase knockdown MDA-MB-231 cells
Rattanapornsompong, K., Khattiya, J., Phannasil, P., Phaonakrop, N., Roytrakul, S., Jitrapakdee, S., & Akekawatchai, C. (2021) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2020.100903 · Cited by 25
Liu, Y., Dong, Y., He, X., Gong, A., Gao, J., Hao, X., Wang, S., Fan, Y., Wang, Z., Li, M., et al. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.651915 · Cited by 25
Roh, J., Im, M., Chae, Y., Kang, J., & Kim, W. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232314808 · Cited by 25
Wang, L., Liu, X., & Yang, Q. (2018) · Biomarkers Journal · doi:10.21767/2472-1646.100050 · Cited by 27
Ammar, N., Hildebrandt, M., Geismann, C., Röder, C., Gemoll, T., Sebens, S., Trauzold, A., & Schäfer, H. (2023) · Antioxidants · doi:10.3390/antiox12101818 · Cited by 27
Wei, X. L., Liu, J., Xu, Z., Wang, D., Zhu, Q., Chen, Q., & Xu, W. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116295 · Cited by 24
Tong, L. (2017) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2017.04.006 · Cited by 26
Stable isotope-resolved metabolomics based on mass spectrometry: Methods and their applications
Yu, D., Zhou, L., Liu, X., & Xu, G. (2023) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2023.116985 · Cited by 25
Beyond glucose and Warburg: finding the sweet spot in cancer metabolism models
Hammond, N. G., Cameron, R. B., & Faubert, B. (2024) · npj Metabolic Health and Disease · doi:10.1038/s44324-024-00017-2 · Cited by 23
Ruiz‐Rodado, V., Lita, A., Dowdy, T., Celiku, O., Saldana, A. C., Wang, H., Yang, C., Chari, R., Li, A., Zhang, W., et al. (2020) · Cancer & Metabolism · doi:10.1186/s40170-020-00229-2 · Cited by 21
Targeting Cancer Metabolism and Current Anti-Cancer Drugs
Sukjoi, W., Ngamkham, J., Attwood, P. V., & Jitrapakdee, S. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-55035-6_2 · Cited by 23
Role and therapeutic targeting of glutamine metabolism in non‑small cell lung cancer (Review)
Zhou, L., Zhang, Q., Zhu, Q., Zhan, Y., Li, Y., & Huang, X. (2023) · Oncology Letters · doi:10.3892/ol.2023.13745 · Cited by 23
GLS and GLS2 Glutaminase Isoenzymes in the Antioxidant System of Cancer Cells
Santos-Jiménez, J. D. L., Campos-Sandoval, J. A., Alonso, F. J., Márquez, J., & Matés, J. M. (2024) · Antioxidants · doi:10.3390/antiox13060745 · Cited by 25
Crooks, D. R., Fan, T. W. ‐., & Linehan, W. M. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9027-6_1 · Cited by 22
Self-citationQuantitative 13C Traces of Glucose Fate in Hepatitis B Virus-Infected Hepatocytes
Wan, Q., Wang, Y., & Tang, H. (2017) · Analytical Chemistry · doi:10.1021/acs.analchem.6b03200 · Cited by 22
Self-citationLiberti, M. V., Allen, A. E., Ramesh, V., Dai, Z., Singleton, K. R., Guo, Z., Liu, J. O., Wood, K. C., & Locasale, J. W. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.010903 · Cited by 24
Metabolic Remodelling: An Accomplice for New Therapeutic Strategies to Fight Lung Cancer
Mendes, C., & Serpa, J. (2019) · Antioxidants · doi:10.3390/antiox8120603 · Cited by 21
Zullo, L., Filippiadis, D. K., Hendriks, L. E. L., Portik, D., Spicer, J. D., Wistuba, I. I., & Besse, B. (2025) · Nature Reviews Disease Primers · doi:10.1038/s41572-025-00642-1 · Cited by 23
NMR Methods for Determining Lipid Turnover via Stable Isotope Resolved Metabolomics
Lin, P., Dai, L., Crooks, D. R., Neckers, L. Μ., Higashi, R. M., Fan, T. W. ‐., & Lane, A. N. (2021) · Metabolites · doi:10.3390/metabo11040202 · Cited by 23
Self-citationComprehensive Analyses of Glucose Metabolism in Glioma Reveal the Glioma-Promoting Effect of GALM
Xu, J., Guo, Y., Ning, W., Wang, X., Li, S., Chen, Y., Ma, L., Qu, Y., Song, Y., & Zhang, H. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.717182 · Cited by 21
Inhibition of Anaplerotic Glutaminolysis Underlies Selenite Toxicity in Human Lung Cancer
Bruntz, R. C., Belshoff, A. C., Zhang, Y., Macêdo, J. K. A., Higashi, R. M., Lane, A. N., & Fan, T. W. ‐. (2019) · PROTEOMICS · doi:10.1002/pmic.201800486 · Cited by 21
Self-citationGrasping for aspartate in tumour metabolism
Fu, A., & Danial, N. N. (2018) · Nature Cell Biology · doi:10.1038/s41556-018-0137-9 · Cited by 19
Physiological impact of in vivo stable isotope tracing on cancer metabolism
Grima-Reyes, M., Martinez-Turtos, A., Abramovich, I., Gottlieb, E., Chiche, J., & Ricci, J. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2021.101294 · Cited by 24
FAIM regulates autophagy through glutaminolysis in lung adenocarcinoma
Han, T., Wang, P., Wang, Y., Xun, W., Lei, J., Wang, T., Lü, Z., Gan, M., Zhang, W., Yu, B., et al. (2021) · Autophagy · doi:10.1080/15548627.2021.1987672 · Cited by 20
Self-citationA distinct holoenzyme organization for two-subunit pyruvate carboxylase
Choi, P. H., Jo, J., Lin, Y.-C., Lin, M.-H., Chou, C., Dietrich, L. E. P., & Tong, L. (2016) · Nature Communications · doi:10.1038/ncomms12713 · Cited by 23
Long non-coding RNA MIR4435-1HG promotes cancer growth in clear cell renal cell carcinoma
Wu, K., Hu, L., Lv, X., Chen, J., Yan, Z., Jiang, J., Cheng, Y., & Hou, J. (2020) · Cancer Biomarkers · doi:10.3233/cbm-201451 · Cited by 20
Comprehensive isotopomer analysis of glutamate and aspartate in small tissue samples
Cai, F., Bezwada, D., Cai, L., Mahar, R., Wu, Z., Chang, M. C., Pachnis, P., Yang, C., Kelekar, S., Gu, W., et al. (2023) · Cell Metabolism · doi:10.1016/j.cmet.2023.07.013 · Cited by 17
Sun, Q., Fan, T. W. ‐., Lane, A. N., & Higashi, R. M. (2019) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2019.115676 · Cited by 19
Self-citationLoss of Rb1 Enhances Glycolytic Metabolism in Kras-Driven Lung Tumors In Vivo
Conroy, L. R., Dougherty, S. M., Kruer, T. L., Metcalf, S. A., Lorkiewicz, P. K., He, L., Yin, X., Zhang, X., Arumugam, S., Young, L. E. A., et al. (2020) · Cancers · doi:10.3390/cancers12010237 · Cited by 19
Aberrant Metabolism as Inductor of Epigenetic Changes in Breast Cancer: Therapeutic Opportunities
Coronel-Hernández, J., Pérez-Yépez, E. A., Delgado-Waldo, I., Contreras-Romero, C., Jacobo-Herrera, N. J., León, D. F. C.-D., & Pérez‐Plasencia, C. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.676562 · Cited by 19
In vivo analysis of lung cancer metabolism: nothing like the real thing
Hensley, C. T., & DeBerardinis, R. J. (2015) · Journal of Clinical Investigation · doi:10.1172/jci79188 · Cited by 19
Effects of Aging on Glucose and Lipid Metabolism in Mice
Lien, E. C., Vu, N., Westermark, A. M., Danai, L. V., Lau, A. N., Gültekin, Y., Kukurugya, M. A., Bennett, B. D., & Heiden, M. G. V. (2024) · Aging Cell · doi:10.1111/acel.14462 · Cited by 22
Shang, H., Zheng, J., & Tong, J. (2020) · Aging · doi:10.18632/aging.104004 · Cited by 18
The Natural History of T Cell Metabolism
Braun, M. Y. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22136779 · Cited by 18
van Heijster, F. H. A., Breukels, V., Jansen, K. F. J., Schalken, J. A., & Heerschap, A. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2024357119 · Cited by 19
UCP2 Overexpression Redirects Glucose into Anabolic Metabolic Pathways
Sreedhar, A., Cassel, T., Smith, P., Lu, D., Nam, H. W., Lane, A. N., & Zhao, Y. (2018) · PROTEOMICS · doi:10.1002/pmic.201800353 · Cited by 20
Self-citationAMPK activation protects astrocytes from hypoxia‑induced cell death
Barialai, L., Strecker, M. I., Luger, A., J�ger, M., Bruns, I., Sittig, A. C. M., Mildenberger, I. C., Heller, S., Delaidelli, A., Lorenz, N. I., et al. (2020) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2020.4528 · Cited by 17
Exhaled metabolic markers and relevant dysregulated pathways of lung cancer: a pilot study
Zou, Y., Hu, Y., Jiang, Z., Chen, Y., Zhou, Y., Wang, Z., Wang, Y., Jiang, G., Tan, Z., & Hu, F. (2022) · Annals of Medicine · doi:10.1080/07853890.2022.2048064 · Cited by 18
Self-citationChihanga, T., Ruby, H. N., Ma, Q., Bashir, S., Devarajan, P., & Kennedy, M. A. (2018) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00500.2017 · Cited by 18
Tang, X., Wu, Y., Yang, J., & Zhu, W. (2021) · Bioengineered · doi:10.1080/21655979.2021.1957072 · Cited by 17
Prognostic Values of TIGAR Expression and 18F-FDG PET/CT in Clear Cell Renal Cell Carcinoma
Wang, X., Li, R., Chen, R., Huang, G., Zhou, X., & Liu, J. (2019) · Journal of Cancer · doi:10.7150/jca.33442 · Cited by 17
Metadata
- Authors
- Sellers, K., Fox, M. P., Bousamra, M., Slone, S. P., Higashi, R. M., Miller, D. M., Wang, Y., Yan, J., Yuneva, M. O., Deshpande, R., Lane, A. N., & Fan, T. W.-M.
- Affiliations
- University of Louisville (US)
- National Institute for Medical Research (GB)
- University of Kentucky (US)
- Corresponding author
- Lane, Andrew N.
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 2015-01-20
- Volume
- 125
- Issue
- 2
- Pages
- 687-698
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC4319441
- OpenAlex
- W2041729369
- Cited by
- 497
- References
- 44
- Citations by year
- 2026: 20 · 2025: 29 · 2024: 41 · 2023: 23 · 2022: 53 · 2021: 63 · 2020: 57 · 2019: 55 · 2018: 44 · 2017: 53 · 2016: 41 · 2015: 17
- FWCI
- 17.09
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Clinical Investigation (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- UKnowledge (University of Kentucky) (submittedVersion)
- Funders
- National Science Foundation (0447479, 0132295)
- University of Louisville (20044)
- Francis Crick Institute (10223)
- National Institutes of Health
- National Cancer Institute (P01CA163223, R01CA118434, R01CA101199, P30CA177558)
- National Institute of Diabetes and Digestive and Kidney Diseases (U24DK097215)
- National Institute of Environmental Health Sciences (R01ES022191)
- National Center for Research Resources (P20RR018733)
- Office of Experimental Program to Stimulate Competitive Research
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
- Keywords
- pyruvate carboxylase, non-small cell lung cancer, anaplerosis, GLS1, TCA cycle, tumor cell proliferation, 13C-labeled glucose, glutamine metabolism, glutathione homeostasis, lipogenesis, nucleotide synthesis, multinucleation, tumor growth
- MeSH terms
- Animals, Carcinoma, Non-Small-Cell Lung, Citric Acid Cycle, Female, Glucose, Glutathione, Humans, Lung Neoplasms, Male, Neoplasm Proteins, Nucleotides, Pyruvate Carboxylase, Radioactive Tracers, Gene Expression Regulation, Enzymologic, Gene Expression Regulation, Neoplastic, Cell Proliferation, Lipid Metabolism, Mice, HEK293 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review